CClinicalTrials.gg
CompletedNCT01984632Updated Jul 31, 2015

Barbed Suture in Single-port Laparoscopic Myomectomy

A Phase 3 interventional study of Single-port laparoscopic myomectomy and Multi-port laparoscopic myomectomy in Uterine Myoma, sponsored by CHA University. Completed at 4 sites in Korea, Republic of. Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2015-07-31.

Sponsored by CHA University · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
Female
01

Study summary

The aim of this study is to test our hypothesis that the use of unidirectional knotless barbed suture in single-port laparoscopic myomectomy could facilitate the suture of uterine wall defect after myoma enucleation as multi-port laparoscopic myomectomy did.

Read the detailed description

The investigators plan to perform a multi-center randomized clinical trial on women scheduled for laparoscopic myomectomy. All women will get the same preoperative and postoperative care. Women will be assigned by chance to one of two groups: one group will receive single-port laparoscopic myomectomy using V-Loc™ suture material (study group). The other group will receive conventional multi-port laparoscopic myomectomy using V-Loc™ suture material (control group). The investigators will collect information on suturing time and complications related to surgery.

02

Conditions studied

  • Uterine Myoma
03

In context

Leiomyoma

490 studies on the registry are indexed under Leiomyoma; 81 are open to participants now.

This study's enrollment of 80 is above the median of 62 across 345 interventional studies indexed under Leiomyoma.

Browse Leiomyoma studies →

Lead sponsor

CHA University is the lead sponsor of 54 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 55 years
  • Image-confirmed uterine myoma
  • Number of myoma ≤2 and largest size ≤10cm
  • Women who were scheduled to have laparoscopic myomectomy
  • Appropriate medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2)

Exclusion criteria

Exclusion Criteria:

  • Women with pedunculated subserosal myoma or submucosal myoma
  • Women undergoing concomitant complex surgical procedures at the time of laparoscopic myomectomy such as severe adhesiolysis or resection for severe endometriosis
  • Women with any suggestion of malignant uterine or adnexal diseases
  • Women with diabetics, malignancy, or malnutrition, which can affect wound healing
  • Women having major medical comorbidity or psychiatric illness, which could affect follow-up and/or compliance
  • Women who refuse to participate or give consent to the procedures
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Single-port laparoscopic myomectomy

    We will use barbed suture (V-Loc) under intervention of single-port laparoscopic myomectomy

    Procedure: Single-port laparoscopic myomectomy

  • Active comparator
    Multi-port laparoscopic myomectomy

    We will use barbed suture(V-Loc) under intervention of multi-port laparoscopic myomectomy.

    Procedure: Multi-port laparoscopic myomectomy

Interventions

  • ProcedureSingle-port laparoscopic myomectomy

    The aim of this study is to compare single-port laparoscopic myomectomy using barbed suture (experimental group) with multi-port laparoscopic myomectomy using barbed suture (control group) in terms of operative time (esp. suturing time).

  • ProcedureMulti-port laparoscopic myomectomy

    The aim of this study is to compare single-port laparoscopic myomectomy using barbed suture (experimental group) with multi-port laparoscopic myomectomy using barbed suture(control group) in terms of operative time (esp. suturing time).

06

What researchers measure

Primary outcomes

  1. Suturing time

    the time duration for the suture of uterine wall defect after myoma enucleation during laparoscopic myomectomy

    Time frame: Intra-operative

Secondary outcomes

  1. Cosmetic satisfaction

    We will compare patient's cosmetic satisfaction through self-reported questionnaire (Body image Questionnaire).

    Time frame: Post-surgery 1 month and 3 month

07

Study locations

4 sites
  • National Health Insurance Service Ilsan Hospital
    Goyang, Korea, Republic of
  • CHA Gangnam Medical Center
    Seoul, Korea, Republic of
  • Kangbuk Samsung Hospital
    Seoul, Korea, Republic of
  • Samsung Medical Center
    Seoul, Korea, Republic of
08

References and documents

Publications

  • Song T, Kim TJ, Lee SH, Kim TH, Kim WY. Laparoendoscopic single-site myomectomy compared with conventional laparoscopic myomectomy: a multicenter, randomized, controlled trial. Fertil Steril. 2015 Nov;104(5):1325-31. doi: 10.1016/j.fertnstert.2015.07.1137. Epub 2015 Aug 8. PubMed 26263079 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01984632
Lead sponsor
CHA University
Responsible party
Taejong Song (Professor, CHA University) — Principal investigator
First posted
Nov 15, 2013
Start date
Nov 2013
Primary completion
Dec 2014
Completion
Dec 2014
Last update
Jul 31, 2015

Study contacts

Taejong Song, MD
principal investigator · CHA Gangnam Medical Center, CHA university, Seoul, Republic of Korea

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion